Skip to main content
. 2021 Jul 20;12(15):1540–1552. doi: 10.18632/oncotarget.28021

Figure 2. Kaplan–Meier curves for overall and relapse-free survival in actionable genes.

Figure 2

(A, C, E) Kaplan–Meier curves for overall survival. (B, D, F) Kaplan–Meier curves for relapse-free survival. (A, B) Actionability. (C, D) PTEN. (E, F) CDKN2A. The differences in overall survival and relapse-free survival were analyzed by log-rank test; P < 0.05 was considered statistically significant.